Agmatine: An endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain

Journal of the Autonomic Nervous System

Volumn 72, Issue 2-3, 1998, Pages 80-85

  Reis, D J ^a   Regunathan, S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Agmatinase; Agmatine; Arginine decarboxylase; Imidazoline receptors; Neurotransmitters

Indexed keywords

AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; ARGININE DECARBOXYLASE; IMIDAZOLINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; PUTRESCINE;

BIOSYNTHESIS; BRAIN; BRAIN SYNAPTOSOME; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DEGRANULATION; DEPOLARIZATION; ENZYME ACTIVITY; HUMAN; NERVE CELL; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; POLYAMINE METABOLISM; PRIORITY JOURNAL; RECEPTOR BINDING;

AGMATINE; ANIMALS; BRAIN; HUMANS; IMIDAZOLES; LIGANDS; NEUROTRANSMITTER AGENTS; RECEPTORS, DRUG;

EID: 0031722357     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(98)00091-5     Document Type: Conference Paper

References (26)

1. Aricioglu-Kartal, F., Uzbay, I.T., 1997. Inhibitory effect of agmatine on naloxane-precipitated abstinence syndrome. Life Sci. 61, 1775-1881.
2. Bradley, K.J., Headley, P.M., 1997. Effect of agmatine on spinal nociceptive reflexes: lack of interaction with alpha2-adrenoceptor or muopioid receptor mechanisms. Eur. J. Pharmacol. 331, 133-138.
3. Feng, Y., Halaris, A.E., Piletz, J.E., 1997. Determination of agmatine in brain and plasma using high-performance liquid chromatography with flourescence detection. J. Chromatogr. 691, 277-286.
4. Glavin, G.B., Carlisle, M.A., Smyth, D.D., 1995. Agmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats. J. Pharmacol. Exp. Ther. 274, 741-744.
5. Gonzalez, C., Regunathan, S., Reis, D.J., Estrada, C., 1996. Agmatine is an endogenous modulator of noradrenergic neurotransmission in the rat tail artery. Br. J. Pharmacol. 119, 677-684.
6. Kalra, S.P., Pearson, E., Sahu, A., Kalra, P.S., 1995. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci. Lett. 194, 165-168.
7. Kolesnikov, Y., Jain, S., Pasternak, G.W., 1996. Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol. 296, 17-22.
8. Li, G., Regunathan, S., Barrow, C.J., Eshraghi, J., Cooper, R., Reis, D.J., 1994. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263, 966-969.
9. Li, G., Regunathan, S., Reis, D.J., 1995. Agmatine is synthesized by a mitochondrial arginine decarboxylase in rat brain. Ann. New York Acad. Sci. 763, 325-329.
10. Molderings, G.J., Gothert, M., 1995. Inhibitory presynaptic imidazoline receptors on sympathetic nerves of rabbit aorta differ from I1 and I2 imidazoline binding sites. Naunyn-Schmiedberg's Arch. Pharmacol. 351, 507-516.
11. Otake, K., Ruggiero, D.A., Regunathan, S., Wang, H., Milner, T.A., Reis, D.J., Regional localization of agmatine in the rat brain: an immunocytochemical study, Brain Res. (1998), in press.
12. Piletz, J.E., Chikkala, D.N., Ernsberger, P., 1995. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J. Pharmacol. Exp. Ther. 272, 581-587.
13. Pinthong, D., Wright, I.K., Hanmer, C., Millns, P., Mason, R., Kendall, D.A., Wilson, V.G., 1995. Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 10-16.
14. Raasch, W., Regunathan, S., Li, G., Reis, D.J., 1995. Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci. 56, 2319-2330.
15. Regunathan, S., Feinstein, D.L., Raasch, W., Reis, D.J., 1995. Agmatine, the decarboxylated arginine is localized and synthesized in glial cells. NeuroReport 6, 1897-1900.
16. Regunathan, S., Reis, D.J., 1996. Imidazoline receptors and their endogenous ligands. Ann. Rev. Pharmacol. Toxicol. 36, 511-544.
17. Regunathan, S., Youngson, C., Raasch, W., Wang, H., Reis, D.J., 1996. Imidazoline receptors and Agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. J. Pharmacol. Exp. Ther. 276, 1272-1282.
18. Reis, D.J., Regunathan, S., 1998. Agmatine: a novel neurotransmitter? Eur. J. Pharmacol. 331, 133-138.
19. Sastre, M., Regunathan, S., Reis, D.J., 1996. Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine. J. Neurochem. 67, 1761-1765.
20. Sastre, M., Regunathan, S., Reis, D.J., 1997. Uptake of agmatine into rat brain synaptosomes: possible role of cation channels. J. Neurochem. 69, 2421-2426.
21. Sener, A., Lebrun, P., Blachier, F., Malaisse, W.J., 1989. Stimulus-secretion coupling of arginine-induced insulin release: insulinotropic action of agmatine. Biochem. Pharmacol. 38, 327-330.
22. Tabor, C.W., Tabor, H., 1984. Polyamines. Ann. Rev. Biochem. 53, 749-790.
23. Wang, H., Regunathan, S., McGowan, D., Bramwell, S., Reis, D.J., 1996. An antiserum to idazoxan recognizes an immunoreactive substance in human serum and cerebrospinal fluid which is not agmatine. Neurochem. Int. 30, 85-94.
24. Wang, H., Regunathan, S., Youngson, C., Bramwell, S., Reis, D.J., 1995. An antibody to agmatine localizes the amine in bovine adrenal chromaffin cells. Neurosci. Lett. 183, 17-21.
25. Yang, X., Reis, D.J., 1997. Agmatine selectively blocks the NMDA subclass of glutamate receptor channels in cultured mouse hippocampal neurons. Soc. Neurosci. Abstr. 23, 1763.
26. Youngson, C., Regunathan, S., Wang, H., Li, G., Reis, D.J., 1995. Coexpression of imidazoline receptors and agmatine in rat carotid body. Ann. New York Acad. Sci. 763, 440-444.